Intratech Medical
Balloon Catheter Therapy for Treatment of Acute Myocardial Infarction
Company Overview
Snapshot
Founded in October 2007 by Eran Hirszowicz and Giora Weisz, Intratech Medical operates with 1–10 employees. The company secured its first funding round in December 2007, with XT Venture Capital participating. In July 2022, Intratech Medical initiated its first-in-human clinical study for its Booster™ coronary sinus spiral balloon therapy.
Business overview
Intratech Medical is a Health Tech & Life Sciences company focused on developing medical devices for cardiovascular health. The company's core product is the Booster balloon catheter therapy, designed to treat acute myocardial infarction by reducing infarct size and improving clinical outcomes. Intratech Medical aims to disrupt ischemic heart disease management and serves the healthcare industry, specifically hospitals and providers, in markets across Europe, the Americas, and Asia.
Strategic signal
In July 2022, Intratech Medical announced the enrollment of patients in its first-ever human study for the Booster™ coronary sinus spiral balloon therapy. This milestone is significant as it marks the transition of their innovative treatment for acute heart attacks from preclinical stages to human clinical trials, signaling potential validation of their technology and a critical step towards commercialization in the medical device market.
Log in to access full profile ›Company Intelligence Q&A
- What is Intratech Medical's primary focus?
- Intratech Medical is focused on developing the Booster balloon catheter therapy to treat patients with acute myocardial infarction by reducing infarct size and improving clinical outcomes.
- When was Intratech Medical founded?
- Intratech Medical was founded in October 2007.
- Who are the founders of Intratech Medical?
- Intratech Medical was founded by Eran Hirszowicz and Giora Weisz.
- What was a significant recent development for Intratech Medical?
- In July 2022, Intratech Medical enrolled patients in its first-ever human study for the treatment of acute heart attacks using its Booster™ coronary sinus spiral balloon therapy.
- What is the current status of Intratech Medical?
- Intratech Medical ceased to operate in August 2025.